Source: BioPortfolio

Nuvectra: Cirtec Announces Acquisition of Intellectual Property to Support Neurostimulation R&D Platform

Cirtec continues to invest in proprietary intellectual property that can accelerate customers time to market with innovative solutions serving the neuromodulation marketMINNEAPOLIS PRWEB March 17 2020 Cirtec Medical Corporation Cirtec a strategic outsourc...

Read full article »
Annual Revenue
$25-100M
Employees
100-250
Fred Parks's photo - CEO of Nuvectra

CEO

Fred Parks

CEO Approval Rating

84/100

Read more